Literature DB >> 23917101

Current and new directions in MRI in multiple sclerosis.

Eric C Klawiter1.   

Abstract

PURPOSE OF REVIEW: This article summarizes the use of MRI in the diagnosis and treatment of multiple sclerosis (MS). Current and emerging imaging techniques are reviewed pertaining to their utility in MS. RECENT
FINDINGS: Conventional T1-weighted and T2-weighted sequences are used to identify and characterize disease pathology in MS. T2 lesion burden, postcontrast enhancement, T1 hypointensities, and regional and global atrophy are all informative and correlate to clinical measures, such as disease disability, to a variable extent. Newer techniques such as diffusion tensor imaging, magnetization transfer imaging, and MR spectroscopy are increasingly being incorporated into clinical trials and may provide improved specificity to the underlying pathology. Double inversion recovery and ultrahigh-field-strength MRI have direct application in MS for evaluating cortical pathology. Newer functional MRI techniques such as resting-state functional connectivity are increasingly being applied in MS.
SUMMARY: Conventional and emerging imaging techniques greatly inform our understanding of MS. These techniques are integral in diagnosis, in evaluating new treatments for MS, and for following patients in the clinical setting.

Entities:  

Mesh:

Year:  2013        PMID: 23917101      PMCID: PMC4234130          DOI: 10.1212/01.CON.0000433283.00221.37

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  46 in total

1.  Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter.

Authors:  Y Ge; R I Grossman; J K Udupa; J S Babb; L G Nyúl; D L Kolson
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

2.  Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water.

Authors:  Sheng-Kwei Song; Shu-Wei Sun; Michael J Ramsbottom; Chen Chang; John Russell; Anne H Cross
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

3.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.

Authors:  M A van Walderveen; W Kamphorst; P Scheltens; J H van Waesberghe; R Ravid; J Valk; C H Polman; F Barkhof
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

4.  Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.

Authors:  Jiwon Oh; Kathleen Zackowski; Min Chen; Scott Newsome; Shiv Saidha; Seth A Smith; Marie Diener-West; Jerry Prince; Craig K Jones; Peter C M Van Zijl; Peter A Calabresi; Daniel S Reich
Journal:  Mult Scler       Date:  2012-08-13       Impact factor: 6.312

5.  MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.

Authors:  Francois Cotton; Howard L Weiner; Ferenc A Jolesz; Charles R G Guttmann
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

6.  Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis.

Authors:  J Pelletier; M Habib; O Lyon-Caen; G Salamon; M Poncet; R Khalil
Journal:  Arch Neurol       Date:  1993-10

7.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

8.  Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.

Authors:  Francesca Bagnato; Neal Jeffries; Nancy D Richert; Roger D Stone; Joan M Ohayon; Henry F McFarland; Joseph A Frank
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

9.  The open ring. A new imaging sign in demyelinating disease.

Authors:  J C Masdeu; J Moreira; S Trasi; P Visintainer; R Cavaliere; M Grundman
Journal:  J Neuroimaging       Date:  1996-04       Impact factor: 2.486

10.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain.

Authors:  Klaus Schmierer; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; David H Miller
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

View more
  12 in total

Review 1.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

2.  Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis.

Authors:  F L Chiang; Q Wang; F F Yu; R S Romero; S Y Huang; P M Fox; B Tantiwongkosi; P T Fox
Journal:  Clin Radiol       Date:  2019-08-14       Impact factor: 2.350

Review 3.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

Review 4.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

5.  Contrast enhancement by combining T1- and T2-weighted structural brain MR Images.

Authors:  Masaya Misaki; Jonathan Savitz; Vadim Zotev; Raquel Phillips; Han Yuan; Kymberly D Young; Wayne C Drevets; Jerzy Bodurka
Journal:  Magn Reson Med       Date:  2014-12-22       Impact factor: 4.668

6.  Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.

Authors:  Ivan de Kouchkovsky; Els Fieremans; Lazar Fleysher; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol       Date:  2016-04-19       Impact factor: 4.849

Review 7.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

8.  Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis.

Authors:  Sean M Tobyne; Wilson B Ochoa; J Daniel Bireley; Victoria Mj Smith; Jeroen Jg Geurts; Jeremy D Schmahmann; Eric C Klawiter
Journal:  Mult Scler       Date:  2017-09-21       Impact factor: 6.312

9.  Recent imaging advances in neurology.

Authors:  Lorenzo Rocchi; Flavia Niccolini; Marios Politis
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

10.  The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.

Authors:  Cyprian Olchowy; Kamil Cebulski; Mateusz Łasecki; Radosław Chaber; Anna Olchowy; Krzysztof Kałwak; Urszula Zaleska-Dorobisz
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.